Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report.

Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy has transformed cancer treatment by activating T-cells—a type of immune ...

Hepatocellular carcinoma, the most common form of primary liver cancer, remains one of the most lethal malignancies in the ...

In Part 1, I discussed how liver cancer is a type of cancer where the causes, high-risk individuals, and appropriate ...